The Week in Review: East/West Biopharma Alliances

Johnson & Johnson is using “external innovation” in China to discover new drugs; Merck and BGI (formerly the Beijing Genomics Institute) will establish a long-term collaboration; Novo Nordisk plans to expand its Beijing R&D center from 100 to 200 employees in five years; Shanghai Institute of Materia Medica will work with the Oslo Cancer Cluster on new cancer therapies; Yunnan Walvax Biotech filed to IPO on the ChiNext Exchange; China Cord Blood plans to spend $6.6 million for a 90% interest in the Zhejiang Blood Center; China Cord Blood also restructured its warrant terms; and Bohai Pharma added five new products to its portfolio. More details…. Stock Symbol: (NYSE: JNJ) (NYSE: MRK) (NYSE: NVO) (NYSE: CO) (OTCBB: BOPH)